In a study published in the Lancet medical journal, Glaxo SmithKline’s AIDS drug Ziagen doubles the risk of heart attack. In the wake of the published study, AIDS doctors are urging caution before abandoning the drug. These antiretrovirals are wonderful and lifesaving, but they do have toxicity problems,” said Charlie Gilks, director of AIDS treatment and prevention at the World Health Organization.
Not surprisingly, Glaxo’s spokesperson argued that internal company research does not support the Lancet findings.
Admitted to practice law in all federal multidistrict litigation courts, the California State Bar and the Florida Bar. His philosophy is to provide aggressive, quality representations and seek fair compensation for individuals and their families who have suffered injury, death, or sexual abuse.
Comments for this article are closed.